CLINICAL_TRIALS
trial_result
· 2015-05-12
Clinical Trial Update: Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery [Phase 2]
Summary
Phase 2 trial evaluating intravenous CR845, a kappa opioid receptor agonist, for analgesia after hysterectomy; the study completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cara Therapeutics, Inc. | Conditions: Acute Pain | Phase 2 | Status: COMPLETED | Results posted: 2015-05-12